Gastroenterologist Mouen Khashab specializes in therapeutic endoscopy, and he oversees this group of practitioners across the Johns Hopkins enterprise. Nationally and internationally known in the field of interventional endoscopy, Dr. Khashab has contributed immensely to the field’s advancement as a minimally invasive means to treat gastrointestinal and pancreaticobiliary disorders. Dr. Khashab earned his medical degree from the American University of Beirut Faculty of Medicine, and subsequently completed a residency in internal medicine and a fellowship in gastroenterology at Indiana University. He then completed a two-year fellowship at The Johns Hopkins Hospital before joining the faculty in 2011. A busy researcher, Dr. Khashab has published more than 600 papers in peer-reviewed journals. In 2013, he described the procedure called gastric peroral endoscopic myotomy (known as G-POEM) and was able to disseminate and teach it all over the world. Other procedures that he expanded include peroral endoscopic myotomy (POEM), peroral endoscopic myotomy with fundoplication (POEM-F), Zenker’s peroral endoscopic myotomy (Z-POEM) and full thickness resection. In 2022, he received the Master Endoscopist Award from the American Society for Gastrointestinal Endoscopy (ASGE) for his numerous contributions to the field. His procedural expertise includes endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), interventional EUS, submucosal endoscopy, POEM/achalasia, endoscopic mucosal resection, endoscopic submucosal dissection, luminal stenting, large polyp resection and Barrett’s therapy, among others. Dr. Khashab is involved with multiple gastrointestinal societies and has served on many committees, including the ASGE Standards of Practice Committee, which is in charge of formulating guidelines for the practice of endoscopy. He has also served as an associate editor for the journal Endoscopy, a premier journal in the field. Khashab is a highly sought-after speaker at national and international conferences, and he has participated in multiple live endoscopy conferences. Outside of academic medicine, Dr. Khashab is an entrepreneur. His major interest is in new technology and medical devices, and his goal is to disrupt the field by introducing technology that makes endoscopic procedures safer, easier, efficient and more scalable. Dr. Khashab is rated as a Distinguished provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Achalasia, Pancreatic Pseudocyst, Bile Duct Obstruction, Endoscopy, and Gastric Bypass.

Dr. Akshintala received his medical degree from the Andhra Medical College in India in 2011. Following this, he completed a post-doctoral research fellowship in Gastroenterology at Johns Hopkins Hospital where he established himself as a dedicated researcher. Dr. Akshintala completed his internship and residency training in Internal Medicine at the University of Pittsburgh Medical Center in 2016. He completed his fellowship in Gastroenterology at Johns Hopkins Hospital in 2019. Dr. Akshintala then completed additional fellowships in Advanced Endoscopy and Medical Pancreatology at the Johns Hopkins Hospital in 2021. As of July 1, 2021, Dr. Akshintala is an Assistant Professor of Medicine in the Division of Gastroenterology at Johns Hopkins Hospital. Dr. Akshintala’s research is focused on the medical as well as endoscopic evaluation and treatment of inflammatory disorders of the pancreas. He is also interested in developing new devices and technologies for the care of patients with gastrointestinal disorders. Dr. Akshintala has conducted multi-national randomized-controlled trials and has won numerous awards at major national and international conferences for his research. He also has authored more than 60 original articles, editorials, book chapters and review articles. Dr. Akshintala has received grant funding from the American Society for Gastrointestinal Endoscopy (ASGE) and the Maryland State to support his research. As an innovator, Dr. Akshintala has patented new therapies for gastrointestinal bleeding and pancreas necrosis, a complication of acute pancreatitis. An internationally recognized researcher conducting multi-national clinical trials, Dr. Akshintala holds an Adjunct Assistant Professor position at the Asian Institute of Gastroenterology in India, one of the largest gastroenterology hospitals in the world. Dr. Akshintala is a Ph.D. candidate with the Dutch Pancreatitis Study Group in the Netherlands, who have been pioneered landmark clinical trials related to pancreatitis. Dr. Akshintala offers in-person clinic visits at the Baltimore location and also provides telemedicine visits for patients located in Maryland, Washington, D.C. and Virginia. Dr. Akshintala is rated as a Distinguished provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Hereditary Pancreatitis, Acute Pancreatitis, Chronic Pancreatitis, Endoscopy, and Lithotripsy.

Dr. Kenneth Ng is an Associate Professor of Clinical Pediatrics and the Director of Endoscopy in the Division of Pediatric Gastroenterology, Hepatology, and Nutrition at the Johns Hopkins University School of Medicine. His professional interests include therapeutic endoscopy, endoscopic innovations, pancreatic diseases, biliary diseases, and esophageal disorders. Dr. Ng received his medical degree from the Rowan University School of Osteopathic Medicine. He completed his pediatric residency at Cohen Children's Medical Center and did his fellowship in pediatric gastroenterology at Baylor College of Medicine. After fellowship, he was an Assistant Professor in the Division of Pediatric Gastroenterology, Hepatology, and Nutrition at Baylor College of Medicine, practicing at Texas Children’s Hospital in Houston, Texas. He joined Johns Hopkins Children’s Center in 2017. Dr. Ng has received awards for his research and clinical work, including the American Liver Foundation Postdoctoral Research Fellowship Award and the Dr. George Ferry Outstanding GI Faculty Award from Texas Children’s Hospital. Dr. Ng is rated as an Advanced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Childhood Pancreatitis, Chronic Pancreatitis, Hepatoblastoma, Endoscopy, and Gastrostomy.

Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Brenda Banwell is the director of the Department of Pediatrics, as well as pediatrician-in-chief and co-director of Johns Hopkins Children’s Center, where she helps manage the hospital’s many clinical and research centers. Dr. Banwell is a renowned expert in the research and treatment of pediatric multiple sclerosis (MS) and other neuroimmune disorders. She specializes in and studies the use of neuroimaging to assess the clinical and cognitive impact of the conditions, as well as the function of the immune system in children with these disorders. She also created a standardized clinical care algorithm and clinical database in order to evaluate the clinical impact of MS. Dr. Banwell has published more than 250 manuscripts in high-impact journals, along with over 25 book chapters. In addition, she has over 200 national and international invited lectureships and visiting professorships. An advocate for pediatric multiple sclerosis needs and research, Dr. Banwell serves as chair of the International Medical and Scientific Board of the Multiple Sclerosis International Federation, and the Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD) International Research Consortium. She is also chair of the pediatric committee of the National Institutes of Health NeuroNEXT program, which conducts studies on treatments for neurological diseases through academic, private, and industry collaborations. Dr. Banwell currently serves as past-chair of the International Pediatric Multiple Sclerosis Study Group, Dr. Banwell earned her medical degree from the University of Western Ontario. She later completed a residency in pediatrics at the University of Western Ontario-Children's Hospital of Western Ontario and a second residency in pediatric neurology at University of Toronto – The Hospital for Sick Children. Her residencies were followed by a fellowship in neuromuscular research at Mayo Clinic. Dr. Banwell is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. Her top areas of expertise are Multiple Sclerosis (MS), CACH Syndrome, Optic Neuritis, and Transverse Myelitis.

Dr. Cameron has had a long and distinguished career in alimentary tract diseases and specifically in pancreatic cancer. He has won worldwide acclaim for mastering the Whipple procedure. At the beginning of his career, the mortality rate from the Whipple procedure was nearly 30 percent. He has worked to lower that to 1 percent to 2 percent at Johns Hopkins. He has operated on more patients with pancreatic cancer and done more Whipple resections than any other surgeon in the world. In addition to maintaining a busy practice that focuses mainly on pancreatic surgery, he has been a leader in the surgical profession, serving as president of the American College of Surgeons, Society for Surgery of the Alimentary Tract, Southern Surgical Association, Society of Clinical Surgery, Society of Surgical Chairmen, Halsted Society and American Surgical Association. He served as chief of surgery for The Johns Hopkins Hospital for nineteen years. Dr. Cameron obtained his undergraduate degree from Harvard University in 1958, and his medical degree from The Johns Hopkins University School of Medicine in 1962. All of his training in General and Thoracic Surgery was obtained at The Johns Hopkins Hospital. Dr. Cameron is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

David J. Hackam, M.D., Ph.D., is the Garrett Family Professor of Pediatric Surgery at The Johns Hopkins University, and Pediatric Surgeon-in-Chief and co-Director of the Johns Hopkins Children’s Center. Dr. Hackam’s clinical practice focuses on complex neonatal surgery. As pediatric surgeon in chief and co-director of the Childrens Center, Dr. Hackam oversees all perioperative clinical operations that involve children, with a strong emphasis on quality and safety, programmatic growth, and system alignment. Dr. Hackam's research is focused on unraveling the mechanisms of necrotizing enterocolitis, which is the leading cause of death in premature infants from gastrointestinal disease. His work has identified a series of novel pathways that, in response to the abnormal microflora that characterizes the premature intestine, leads to intestinal mucosal barrier breakdown, bacterial translocation, mesenteric vasoconstriction, and NEC. In seeking to translate these findings to clinical studies, we have developed a family of molecules that can prevent NEC development, and which have in part been licensed for clinical development. In additional work, Hackam has developed a prototype artificial intestine, derived from patient-specific intestine stem cells, which we have implanted into pre-clinical models, for the treatment of short bowel syndrome, a devastating complication of NEC. Finally, using single-cell RNA-seq and cell tracking technology, Hackam has worked towards understanding and treating NEC-associated brain injury, a major complication of NEC, and has engineered nanoparticle-packaged molecules that can cross the blood-brain barrier, and reverse the processes that lead to this disease. These studies are funded by three ro1s, a T32, a MIRA (a maximizing investigators’ research award) and 3 industry grants from companies with an interest in NEC treatment and prevention. Dr. Hackam seeks to work with industry partners, as well as nurses, doctors, and families of patients around the country, in order to develop novel regimens to safely and effectively deliver appropriate nutrition to the most vulnerable infants, who are at risk for the development of intestinal disease. Dr. Hackam is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Necrotizing Enterocolitis, Necrosis, Short Bowel Syndrome, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Dr. Wikrom Karnsakul is an associate professor of pediatrics at the Johns Hopkins University School of Medicine. His clinical interests are in the care of pediatric liver diseases, and general gastrointestinal diseases. Dr. Karnsakul received his medical degree in 1992 from Faculty of Medicine, Siriraj Medical Center, Mahidol University School of Medicine in Bangkok, Thailand. He completed his residency in pediatrics at Advocate Hope Children's Hospital in 1998 and did a fellowship in pediatric gastroenterology, hepatology and nutrition at Texas Children's Hospital, Baylor College of Medicine in Houston, Texas. He completed his postdoctoral research training at USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine. He joined the faculty at Johns Hopkins in 2008. His research interests center on the understanding and treatment of chronic liver disease, ascites, cholestasis, viral hepatitis especially hepatitis C and hepatitis E, and Cystic Fibrosis Related Liver Disease. Dr. Karnsakul is also involved in NIH-funded multicenter research studies including the Cholestatic Liver Disease Consortium and Cystic Fibrosis Related Liver Disease Project. Dr. Karnsakul is currently a Fellow of the American Association for the Study of Liver Diseases (FAASLD). Dr. Karnsakul is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Alagille Syndrome, Cholestasis, Hepatitis E, Liver Transplant, and Endoscopy.

Dr. James Facciola is a clinical instructor in the Johns Hopkins Medicine Department of Radiology and Radiological Sciences. He specializes in body magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and image-guided biopsy. Dr. Facciola graduated from the Temple University School of Medicine in 2013. He subsequently completed a preliminary surgical internship at Temple University Hospital in Philadelphia, PA followed by a diagnostic radiology residency at Temple University Hospital. Following residency, he completed a year-long fellowship in cross-sectional imaging at Johns Hopkins. Dr. Facciola’s research has included study of the anatomic changes seen in the male and female pelvis in children with bladder exstrophy. He joins the Johns Hopkins faculty in July 2019. Dr. Facciola is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Pleurisy, Exstrophy of the Bladder, Pleural Effusion, and Pancreatic Cancer.

Semenawit Burka is a primary care provider, practicing in Cardiologist in Baltimore, Maryland. Dr. Burka is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. Her top areas of expertise are Pericarditis, Acute Kidney Failure, High Cholesterol, and Coronary Heart Disease.

Dr. Bull-Henry joins Johns Hopkins as a hospitalist specializing in small bowel imaging, including single balloon enteroscopy, double balloon enteroscopy and wireless video capsule endoscopy. In addition, she has a special interest in small bowel GI bleeding, innovation in medical education and the use of artificial intelligence to attain greater diagnostic efficiencies, to improve patient outcomes and to achieve cost savings. Dr. Bull-Henry is active in her research. She has also published papers, contributed to book chapters and written abstracts on related clinical topics. Dr. Bull-Henry is active in a number of professional societies and currently serves on the Board of Governors and as Chair of the Training Committee for the American College of Gastroenterology. Videos Double Balloon EnteroscopyFAQ with Dr. Bull-Henry. Dr. Bull is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. Her top areas of expertise are Angiodysplasia of the Colon, Gastroparesis, Painful Swallowing, Endoscopy, and Colonoscopy.

John Affronti is a Gastroenterologist in Baltimore, Maryland. Dr. Affronti is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Childhood Volvulus, Portal Hypertension, Indigestion, Endoscopy, and Gastrectomy.

Gastroenterologist Saowanee Ngamruengphong specializes in the endoscopic diagnosis and management of gastrointestinal malignancies, premalignant and malignant lesions in the gastrointestinal tract (e.g., early gastric cancer, Barrett's esophagus-associated neoplasia), esophageal cancer, colon polyps or early colorectal cancer, and pancreatic and biliary disease. Dr. Ngamruengphong earned a medical degree from Chulalongkorn University and completed residency training at the Texas Tech University Health Sciences Center. She undertook fellowship training in gastroenterology at the Mayo School of Graduate Medical Education and further fellowship training in therapeutic endoscopy at The Johns Hopkins Hospital. Her research interests include endoscopic resection and the management of precancerous or cancerous gastrointestinal lesions. Dr. Ngamruengphong is a member of several professional organizations, including the Thai Medical Council, the American College of Gastroenterology and the American Gastroenterological Association. Videos Endoscopic Submucosal Dissection (ESD) — Eileen’s Story Recent News Articles and Media Coverage A Rare, Stomach-Saving Endoscopic Procedure, Inside Tract (Spring 2021) Case Presentation: ESD-TAMIS, Inside Tract (Spring 2019) Innovative Approaches to Colorectal Surgery Benefit Patients, Surgery (Winter 2019) For Colorectal Polyps: Early Detection and Minimally Invasive Endoscopic Resection, Inside Tract (Winter, 2019) The Cutting Edge of Endoscopic Resection, Inside Tract (Spring, 2017) Stomach Cancer: Know Your Risks & Treatment Options, Johns Hopkins Surgery (4/26/2017). Dr. Ngamruengphong is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. Her top areas of expertise are Achalasia, Pancreatic Pseudocyst, Stomach Cancer, Endoscopy, and Gastric Bypass.

Dr. Cunningham earned his M.D. from George Washington University and completed general surgery residency at the University of Maryland. He has completed fellowships in both oncology research and pancreatic and hepatobiliary surgery at Johns Hopkins Hospital. Throughout his career, he has been a prolific contributor and editor with over 100 contributions to a variety of medical journals, guidelines, conferences and textbooks [see Research tab]. He has also served as a Cancer Liaison Physician for the American College of Surgeons, Commission on Cancer. A member the American College of Surgeons, the Society for American Gastrointestinal & Endoscopic Surgeons, the Americas Hepato-Pancreato-Biliary Association, the International Hepato-Pancreato-Biliary Association, the Society for Surgical Oncology, the Society for Surgery of the Alimentary Tract, and the Pancreas Club, Dr. Cunningham offers world-class multidisciplinary and minimally invasive evaluation and treatment of pancreatic, biliary and liver diseases, both benign and malignant. LinkedIn https://www.linkedin.com/in/stevenccunningham. Dr. Cunningham is rated as an Experienced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Biliary Dyskinesia, Gallbladder Disease, Pancreatic Cancer, Gallbladder Removal, and Pancreaticoduodenectomy.

Agazi Gebreselassie is a Gastroenterologist and a Hospital Medicine provider in Baltimore, Maryland. Dr. Gebreselassie is rated as an Advanced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Jaundice, Macroamylasemia, Portal Hypertension, Endoscopy, and Colonoscopy.

Ernest Tsao is a Gastroenterologist in Baltimore, Maryland. Dr. Tsao is rated as an Advanced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Hepatitis, Gas Bloat Syndrome, Hepatitis C, Endoscopy, and Gastrectomy.

Dr. Onwueme graduated with Distinction from Yale University with dual BSc/MSc degrees in chemistry and received MD and PhD degrees from Weill Cornell Medical College. He completed his Internal Medicine residency at Brigham and Women’s Hospital (Clinical Fellow Harvard Medical School) and his Gastroenterology fellowship at Johns Hopkins University School of Medicine. He is currently the Director of clinical trials at Woodholme Gastroenterology and has an ardent interest in the role of microbial metabolites in gut diseases. Dr. Onwueme prizes commitment to quality and compassionate patient care to which he devotes his practice. He has expert knowledge in gut microbiology and a special interest in diarrheal diseases, disordered gut motility, autoimmune and inflammatory bowel disease. Dr. Onwueme is rated as an Advanced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Gastric Dysmotility, Diverticular Disease, Diarrhea, Endoscopy, and Gastrectomy.

Vikesh Singh is a gastroenterologist who specializes in pancreatology and pancreaticobiliary endoscopy. He evaluates and treats patients with inflammatory diseases of the pancreas, including acute and chronic pancreatitis and autoimmune pancreatitis as well as the complications of these diseases. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Singh remained at Johns Hopkins to complete residency training in internal medicine. He pursued fellowship training in gastroenterology at Brigham and Women’s Hospital, and earned a master’s degree in epidemiology from the Harvard T. H. Chan School of Public Health. He then returned to Johns Hopkins, where he completed a two-year advanced endoscopy fellowship with a focus on pancreaticobiliary endoscopy. Dr. Singh has been on the faculty at Johns Hopkins since 2008, and rose to the rank of professor in 2021. His research interests include acute and chronic pancreatitis, autoimmune pancreatitis, exocrine pancreatic insufficiency, and novel methods to evaluate and treat abdominal pain. Dr. Singh is a member of the board of directors of the National Pancreas Foundation, chair of the Pancreatic Disorders Section of the American Gastroenterological Association, a councilor for the International Association of Pancreatology and a member of the inaugural medical advisory board for the Familial Chylomicronemia Syndrome Foundation. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Exocrine Pancreatic Insufficiency, Hereditary Pancreatitis, Acute Pancreatitis, Pancreatectomy, and Endoscopy.

Peter Darwin is a Gastroenterologist in Baltimore, Maryland. Dr. Darwin is rated as an Advanced provider by MediFind in the treatment of Childhood Pancreatitis. His top areas of expertise are Cholestasis, Bile Duct Obstruction, Bile Duct Stricture, Endoscopy, and Pancreatectomy.